BIRC5 and colorectal cancer: As survivin is suppressed by acetylsalicylic acid (ASA), an agent used as chemoprevention for colorectal cancer [13, 14], we studied the therapeutic potential of ASA in pituitary tumours, and assess its potential effects on survivin.